Approval · Notice of Compliance 18761 · 2016
ZOCOR: Notice of Compliance 18761
Issued December 14, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18761
- Date
- December 14, 2016
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Remove 5 mg strength from the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOCOR | Not yet assigned | — |
Medicinal ingredients
- SIMVASTATIN 10 MG per TAB
- SIMVASTATIN 20 MG per TAB
- SIMVASTATIN 40 MG per TAB